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The explosion of new information in recent years on the origin of macrophages in the
steady-state and in the context of inflammation has opened up numerous new avenues
of investigation and possibilities for therapeutic intervention. In contrast to the classi-
cal model of macrophage development, it is clear that tissue-resident macrophages can
develop from yolk sac-derived erythro-myeloid progenitors, fetal liver progenitors, and
bone marrow-derived monocytes. Under both homeostatic conditions and in response to
pathophysiological insult, the contribution of these distinct sources of macrophages varies
significantly between tissues. Furthermore, while all of these populations of macrophages
appear to be capable of adopting the polarized M1/M2 phenotypes, their respective con-
tribution to inflammation, resolution of inflammation, and tissue repair remains poorly
understood and is likely to be tissue- and disease-dependent. A better understanding of
the ontology and polarization capacity of macrophages in homeostasis and disease will
be essential for the development of novel therapies that target the inherent plasticity of
macrophages in the treatment of acute and chronic inflammatory disease.
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Macrophages are a heterogeneous population of immune cells
that have a range of roles in both the induction and resolu-
tion of inflammation. Tissue-resident macrophages promote tis-
sue homeostasis and exhibit unique transcriptional profiles and
characteristics depending on the tissue in which they reside (1).
For instance, alveolar macrophages regulate pulmonary surfac-
tant turnover while osteoclasts promote bone resorption, and
red-pulp macrophages (RPMs) in the spleen promote red blood
cell clearance and regulate iron recycling. In addition, multiple
macrophage subtypes occur within a given tissue, and they can
perform distinct functions depending on their anatomical location
(2). For example, in the bone there are at least two types of tissue
macrophages. TRAP+F4/80− osteoclasts promote bone resorp-
tion while F4/80+CD169+TRAP− tissue-resident macrophages
promote red blood cell development by providing a niche that
promotes erythropoiesis and engulfing the extruded nuclei of
red blood cell (RBC) progenitors at late stages of develop-
ment (Figure 1A). Depletion of CD169+ macrophages results in
impaired recovery of mice from hemolytic anemia (3). Recent
studies suggest these two macrophage populations in the bone
are replenished by distinct subsets of monocytes in response to
stress. Mac3+F4/80− monocytes regulate osteoclast activity but
are not thought to be precursors of osteoclasts under homeosta-
tic conditions (Figure 1A). However, these cells can differentiate
into osteoclasts under inflammatory conditions. Alternatively, in
the presence of increased levels of extracellular heme resulting
from conditions of stress such as hemolytic anemia, a subpopu-
lation of monocytes in the bone marrow and spleen develop into
F4/80+CD11bhi progenitors termed pre-RPMs and subsequently
into RPMs and F4/80+VCAM+ bone marrow macrophages that
resemble RPMs to re-establish iron homeostasis (Figure 1A) (4).
In the developing embryo, hematopoiesis begins in the yolk
sac where primitive erythrocytes and macrophages develop in
the absence of hematopoietic stem cells (HSCs). Subsequently,
HSCs arise in the aorto-gonado-mesonephric (AGM) region
and eventually migrate to the fetal liver where development of
all hematopoietic lineages from HSCs occurs. In the neonate,
hematopoiesis moves from the fetal liver to the bone marrow
where it persists throughout adulthood. The traditional view of
macrophage origin contended that tissue-resident macrophages
develop from bone marrow-derived monocytes. It was subse-
quently believed that tissue-resident macrophages derive from
Ly6C− “resident” monocytes that traffic to tissues under home-
ostatic conditions. However, studies utilizing Runx1CreER and
Csf1CreER mice, which allow for tamoxifen-inducible activation
of Cre during the early stages of yolk sac hematopoiesis crossed
with Rosa26 mice to label yolk sac-derived (YS) cells (5) have
indicated that some tissue macrophages arise from the yolk sac
and seed tissues in the embryo where they repopulate through-
out adulthood (6, 7). Studies utilizing Flt3Cre mice to mark
HSC-derived macrophages confirm that YS tissue macrophages
(Flt3Cre−) are distinct from HSC-derived macrophages (Flt3Cre+)
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FIGURE 1 | Differentiation of resident macrophages in various
physiological states. (A) Two tissue macrophage populations reside in
bone, F4/80− TRAP+ osteoclasts and F4/80+ CD169+ TRAP−
tissue-resident macrophages (MΦs). Osteoclasts are developmentally
dependent on Mac3+F4/80− monocytes but only during inflammation.
Alternatively, tissue-resident macrophages in bone can be maintained by a
heme-induced subset of monocytes (CD11bhi Ly6C+ SPI-C−). (B) Cardiac
tissue-resident macrophage populations are primarily yolk sac-derived
(YS) however a minor subset of the population is derived from fetal liver
and HSC-derived progenitors. In homeostasis, primary yolk sac-derived
cardiac resident macrophages are maintained through self-renewal but in
response to cardiac insult, Ly6Chi monocytes contribute to all four
macrophage populations. (C) Selective transcriptional control plays an
important role in the development of different types of macrophage
populations. While red-pulp macrophages are dependent on SPI-C activity
for development and maintenance, marginal zone (MZ) macrophage
differentiation is mediated by LXRα. Alternatively, Gata6 is mandatory for
the differentiation and proliferation of peritoneal macrophages while
GM-CSF-dependent induction of PPARγ regulate alveolar macrophage
development.
thus challenging the traditional view of macrophage ontogeny.
Kupffer cells, microglia, and cardiac tissue macrophages are pri-
marily YS and are maintained throughout adulthood. These cells
are independent of the transcription factor Myb, which is required
for the development of HSCs, suggesting these populations of
tissue-resident macrophages develop and persist independent of
contribution from HSCs (8).
While Langerhans cells are first seeded by yolk sac macrophages,
these cells are largely replaced by fetal liver-derived mono-
cytes at later stages of embryonic development as demonstrated
by adoptive transfer of fetal liver monocytes to host embryos
(9). In addition, studies utilizing the CX3C chemokine receptor
1 (CX3CR1) promoter, which marks fetal-derived resident
macrophage populations to drive GFP, Cre or a tomoxifen-
inducible Cre together with adoptive transfer studies have demon-
strated that peritoneal macrophages and alveolar macrophages are
also largely fetal liver-derived. While cardiac tissue macrophages
are also largely YS, two minor populations also display contribu-
tion from fetal liver and bone marrow progenitors (10–12). Other
tissue-resident macrophages including those from spleen, pan-
creas, and kidney also exhibit mixed contribution from fetal and
adult HSC-derived precursors (13), while intestinal macrophages
appear to be entirely derived from circulating monocytes (14, 15).
While these studies make a distinction between YS and fetal liver-
derived macrophages,a recent report describes an erythro-myeloid
progenitor (EMP) population that develops in the yolk sac and
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later migrates to the liver. These progenitors are distinct from
HSC-derived hematopoiesis, suggesting that YS and fetal liver-
derived tissue-resident macrophages have a common origin in the
yolk sac (16).
Unlike previous assumptions that macrophages are terminally
differentiated cells, YS macrophages appear to have stem cell-
like properties in that they can proliferate and self-renew (9).
In the lung, tissue-resident macrophages are maintained locally
in the steady state. Moreover, following irradiation and bone
marrow transplantation, residual lung-resident macrophages can
re-establish normal homeostasis when the development of donor-
derived macrophages is compromised (13). These cells expand in
response to colony-stimulating factors, M-CSF and GM-CSF, in
an interleukin 4 (IL-4)-independent manner. It is therefore likely
that, following irradiation, the expansion of resident macrophages
is delayed giving the monocyte-derived macrophages a develop-
mental advantage. Alternatively, in response to helminth infec-
tion, Th2-dependent production of IL-4 promotes the pro-
liferation of lung-resident macrophages (17) and this prolif-
eration is independent of colony-stimulating factor-1 (CSF-1)
(18). However, while Langerhans cells are embryonic-derived
cells that exhibit hallmarks of self-maintenance, these cells are
eventually replaced by circulating precursors following non-
myeloablative transplantation (19). Similarly, YS cardiac resident
macrophages are maintained through local proliferation, while
monocyte-derived cells can replace all populations of resident car-
diac macrophages following depletion or in response to damage
(Figure 1B) (10, 20).
The development and maintenance of tissue-resident
macrophages is also under tissue-selective transcriptional control.
The transcription factor Gata6 is responsible for the transcrip-
tome profile of resident peritoneal macrophages as well as for
their proliferation under homeostatic conditions and in response
to inflammation (Figure 1C) (21) and this programing is regu-
lated reversibly by retinoic acid-induced Gata6 expression (22).
Reflecting the fetal origin of peritoneal macrophages, retinoic
acid induces expression of Gata6 in fetal-derived macrophages
but not bone marrow-derived macrophages (BMDMs) due to
epigenetic silencing of the Gata6 locus in BMDMs (22). Alter-
natively, the development of alveolar macrophages from fetal
monocytes shortly after birth is regulated by the GM-CSF-
dependent induction of peroxisome proliferator-activated recep-
tor γ (PPARγ), resulting in a transcriptosome profile unique
to alveolar macrophages (Figure 1C) (23). The development
of splenic RPMs in response to excess heme requires the tran-
scription factor SPI-C (Figure 1C) (4), however, marginal zone
(MZ) macrophages develop normally in SPI-C knockout ani-
mals. MZ macrophages play a critical role in the recognition
and uptake of blood-borne antigens. While the differentiation
of RPMs requires SPI-C, the differentiation of both popula-
tions of MZ macrophages is under the regulatory control of the
nuclear receptor, liver x receptor α (LXRα) (Figure 1C) (24), and
LXRα-deficient mice exhibit abnormal responses to blood-borne
antigens.
Unlike previous assumptions that Ly6C− monocytes are pre-
cursors of tissue-resident macrophages, it has recently been
shown that these monocytes do not infiltrate tissues but rather
have a “patrolling” function in promoting endothelial integrity.
Alternatively, Ly6C+ “inflammatory” monocytes are actively
recruited to inflamed tissues by the chemokine, chemokine lig-
and 2 (CCL2) where they promote inflammation and pathogen
clearance. Analogous populations of monocytes in humans have
been described based on gene expression analysis and are classi-
fied as CD14hiCD16−, which are the primary subset in healthy
individuals and resemble Ly6C+ murine monocytes while the
minor CD14loCD16+ population of human monocytes shares
gene expression profiles with murine Ly6C−monocytes (25). Fur-
thermore, the CD14loCD16+ population of human monocytes,
like Ly6C− monocytes, also play a role in patrolling the endothe-
lium (26). Ly6C− monocytes derive in the circulation from the
Ly6C+ population and exhibit an extended half-life compared
with Ly6C+ monocytes (9). Intriguingly, recent studies indicate
that a subset of Ly6C+ monocytes can traffic to tissues under
homeostatic conditions where they fail to differentiate into tissue-
resident macrophages, rather they acquire antigen, which they
carry to the draining lymph nodes (27).
Under non-inflammatory conditions, tissue-resident macro-
phages largely exhibit an M2 phenotype that promotes tissue
homeostasis and repair. However, upon infection, M1 macrophage
activation is induced by the engagement of pattern recogni-
tion receptors (PPRs) by pathogen-associated molecular patterns
(PAMPs) such as lipopolysaccharide (LPS), in cooperation with
interferon γ (IFNγ) (28). These cells produce cytotoxic oxygen
and nitrogen radicals and pro-inflammatory cytokines resulting
in increased microbicidal activity. M2 macrophage activation is
induced by the Th2 chemokines IL-4 and interleukin-13 (IL-13)
(29, 30). Alternatively, during the resolution of inflammation, the
balance of macrophage activation toward an M2 phenotype occurs
in order to promote clearance of debris, inhibit the production
of inflammatory mediators, and restore tissue homeostasis. M2
macrophages produce anti-inflammatory cytokines and express
endocytic receptors, and these cells promote the clearance of apop-
totic cells, proliferation, and wound healing (28). However, the
relative contribution and level of plasticity of tissue-resident ver-
sus monocyte-derived macrophage populations is only recently
beginning to be elucidated.
The M1/M2 macrophage subsets are most commonly dis-
tinguished based on the catabolism of l-arginine. While classi-
cally activated macrophages express increased levels of inducible
nitric oxide synthase (iNOS), which converts l-arginine to l-
citrulline and nitric oxide, alternatively activated macrophages
express arginase I (ArgI), which catabolizes l-arginine to l-
ornithine, a precursor of polyamines and proline. While Th1
and Th2 cytokines promote M1 and M2 macrophage activation,
respectively, these phenotypes are observed in T cell deficient mice
suggesting that T helper cells are not required to drive macrophage
polarization in vivo (29, 30). Conversely, M1 and M2 macrophages
are capable of promoting Th1 and Th2 differentiation, respectively,
suggesting these polarized macrophage phenotypes play an impor-
tant role in driving the immune response to environmental insult
(29). Recent attempts have been made to re-classify macrophage
subpopulations in response to a range of stimuli and increas-
ingly complex combination of markers (31). However, in vivo,
macrophages are exposed simultaneously to a diverse array of
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signals, so it remains to be determined to what extent distinct
subpopulations exist in vivo.
The origin and plasticity of macrophages in chronic inflamma-
tion remains poorly understood and is likely variable depending
on the tissue and the underlying cause of inflammation. Tissue-
resident macrophages as well as monocyte-derived macrophages
appear to have the capability of adopting both M1 and M2 phe-
notypes, however, the relative contribution of these subsets of
macrophages to the progression and resolution of chronic inflam-
mation remains enigmatic. Here, we will review current progress in
understanding the complex relationships between tissue-resident
macrophages and infiltrating monocyte-derived macrophages in
homeostasis and chronic inflammation and their contributions to
M1/M2 polarized phenotypes in homeostasis and disease with a
focus on chronic inflammation in the brain, adipose tissue, and
liver.
MICROGLIA: RESIDENT CNS MACROPHAGES
Microglia, parenchymal tissue-resident macrophages in the central
nervous system, plays a central role in mediating tissue homeosta-
sis in health and disease (32). Fate mapping studies conducted
independently by Ginhoux et al. and Prinz et al. demonstrated the
embryonic origin of microglia from c-kit+ EMP prior to the for-
mation of blood–brain barrier and vascularization of the embryo
(7, 33, 34). The colony-stimulating-factor 1 receptor (CSF1R) and
its ligand, CSF-1, play a central role in macrophage development
and maintenance. However, while CSF1R is essential for the devel-
opment and maintenance of microglia, mice deficient for CSF-1
exhibit only a partial reduction in microglial cells. Recent stud-
ies have identified an additional ligand for CSF1R, interleukin-34
(IL-34), which plays an essential role in the development and
maintenance of microglia. While mice deficient for IL-34 exhibit
significantly decreased numbers of microglia and Langerhans cells,
the development of other tissue macrophage populations remain
largely intact (35, 36). After birth, the microglia undergo massive
expansion in response to CSF-1 and IL-34 in order to populate
the developing nervous system. Cortical, optical, and spinal cord
microgliogenesis is sustained by the transcription factors Pu.1 and
interferon regulatory factor-8 (IRF-8), and is independent of Myb,
which is required for the development of hematopoietic stem cells
(34, 37). Microglia are sustained and self-renew within host tissues
throughout adulthood independent of progenitors from the bone
marrow (38).
In a healthy brain, microglia are dispersed relatively uniformly
throughout the parenchymal tissue. Microglia are characterized
by morphological features that reflect their functional capacity.
In a healthy brain, microglia are in a quiescent state or have a
“down-regulated” phenotype exhibited by a ramified shape, sim-
ilar to Langerhans cells that have short fine processes and thus
increased surface area for tissue surveillance (39). This down-
regulated phenotype is characterized by an attenuated innate
immune function correlated with decreased expression of CD45,
MHCII, and Fc receptors (39–41). Initially, it was believed that
steady-state microglia are static, however, recent studies have char-
acterized the quiescent phenotype as a more dynamic state in
which microglia are performing housekeeping functions by con-
stitutively surveying the parenchymal tissue (42). This dynamic
state is characterized by increased expression of oxidative genes
and favors homeostatic tissue remodeling and steady-state wound
healing (43).
Recent studies by Butofsky et al. (44) demonstrate that res-
ident microglia exhibit a distinct expression profile that is not
observed in microglial cell lines and is distinct from M1 or M2
polarized microglia, but rather includes genes associated with
nervous system development. The induction of this unique pro-
file is highly dependent on transforming growth factor β (TGF-
β) – in vitro in human microglial cultures, and these cells are
absent in TGF-β knockout mice. The down-regulated phenotype
of microglia is critical for normal neuronal growth, and inti-
mate interactions between neurons and microglia are important
for optimal synaptic growth and maintenance (Figure 2) (45).
The interaction between neurons and microglia is fostered by
the chemokine CX3C chemokine ligand 1 (CX3CL1; also known
as fractalkine) and CD200 membrane proteins expressed on
healthy neurons that interact with their respective transmembrane
protein receptors on microglia, CX3CR1, and CD200R, respec-
tively (32, 46–48). These microglial receptors carry immunore-
ceptor tyrosine-based inhibitory motifs (ITIMs) such that, upon
ligand–receptor interaction, the ITIM based receptors suppress
downstream immune signaling through the recruitment of Src
homology 2 domain-containing phosphatase 1 (SHP-1) (32, 48–
50). These cell–cell mediated interactions act synergistically with
constitutively released neurotropic elements in order to cre-
ate an environment fostering the down-regulated phenotype of
microglia.
Whether or not bone marrow-derived cells can contribute to
the microglial population remains under debate (reviewed in Prinz
et al.). Bone marrow transplantation of irradiated recipient mice
demonstrated that macrophages in the perivascular space and
choroid plexus can be repopulated by donor cells (51, 52). While
microglia are largely radio-resistant cells, upon irradiation and
bone marrow transplantation, bone marrow-derived progenitor
cells that are distinct from monocytes have been shown to seed
the brain and differentiate into microglial-like macrophage cells
(45). However, it is not clear whether BMDMs maintain the range
of functions exhibited by YS microglia. In addition, irradiation
results in the breakdown of the blood–brain barrier, thus whether
the seeding of the brain with peripheral bone marrow-derived
cells can occur under steady-state conditions in the presence of an
intact blood–brain barrier is not known.
Like macrophages in the periphery, in vitro studies demon-
strate that M1 and M2 activation can be induced in microglia by
LPS and IL-4, respectively (40, 53). However, whether this phe-
notypic switching of resident microglia occurs in vivo remains
unclear. Experimental models of Alzheimer’s disease (AD), aging,
and multiple sclerosis (MS) (54, 55) have demonstrated microglial
heterogeneity analogous to systemic tissue-resident populations.
These studies suggest that early in disease progression, microglial
cells develop an altered inducible “activated” state that is function-
ally different from steady-state microglia. This activated state is
then further subdivided into a classical M1 and alternative M2
state (32, 40). Morphologically, activated microglia exhibit an
amoeboid shape in contrast to the quiescent ramified shape of
steady-state microglia (42). While the quiescent state of microglia
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FIGURE 2 | Microglial–neuronal interactions in health and disease.
Healthy neurons expressing chemokine fractalkine (CX3CL1) and CD200
membrane proteins intimately interact with their respective transmembrane
protein receptors on microglia, CX3CR1, and CD200R to sustain a
down-regulated microglial phenotype. Microglial receptors have
immunoreceptor tyrosine-based inhibitory motifs (ITIMs), which upon
ligand–receptor activation suppresses downstream immune signaling through
the recruitment of phosphatases including SHP-1. Chronic inflammation
disrupts this intimate neuronal–glial interaction, thus releasing the microglial
cells from a down-regulated inhibited state to an activated phenotype.
is maintained by neuronal–glial interactions, in the course of
inflammation, neuronal, and glial interactions are disrupted due
to degeneration of neurons (43, 56). Disruption of CX3CL1–
CX3CR1 interactions releases microglia from tonic inhibition (48),
resulting in microglial activation as a consequence (Figure 2).
Additionally, a unique “primed” microglial state, which exhibits
a functional state somewhat distinct from the activated states,
has been described (57). These microglia are thought to func-
tion as more of an adaptive response (57). This primed state
refers to a mode of preconditioning underlying chronic inflamma-
tion whereby microglial cells are activated continuously by being
persistently exposed to a pro-inflammatory milieu (32,57). Impor-
tantly this priming state enables the conditioned microglia to
mount a heightened response to secondary or future immunolog-
ical insult in the course of disease progression. Primed microglia
exhibit a more robust inflammatory response as compared to
those that were not subjected to prior stimulatory challenges
(32, 57). Additionally, the heightened inflammatory response to a
physiological challenge is believed to promote a switch from a more
anti-inflammatory to a pro-inflammatory reactive phenotype
resulting in cellular stress and exacerbated inflammation (57).
Investigations in spinal cord injury (SCI), AD, and the animal
model of MS, also known as experimental autoimmune encephali-
tis (EAE) demonstrate an increase in both M1 and M2 phenotypes,
possibly acting synergistically in an attempt to mitigate inflam-
mation (40). While both M1 and M2 transcripts increase in a
majority of chronic CNS disease models, the M1 phenotype off-
sets the M2 phenotype in the early stages of chronic inflammation,
disrupting normal neuronal/glial cross-talk, and promoting a pro-
inflammatory milieu implicated in the progression of disease (39,
40, 53). With progressive degeneration, the M1 phenotype pre-
dominates, as M2 microglia exhibit decreased responsiveness to
anti-inflammatory cues (53). Alternatively, the classically activated
M1 phenotype is predominately induced by acute pathological
conditions such as stroke, traumatic brain injury, or experi-
mentally induced systemic inflammation by LPS (42). The M1
state in chronic and acute manifestations is characterized by the
up-regulation of MHCII, CD86, and Fc receptors and increased
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production of pro-inflammatory cytokines such as interleukin-
6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor alpha
(TNFα) (58). Furthermore aging models hint at a possibility of
phenotypic switch in microglial activation from an M2 to M1
state over time, coincident with decreasing neurogenesis and a
growing inflammatory niche (32). However, it still remains unclear
whether these populations of macrophages are due to phenotypic
switching of resident microglia, or the activation states of infil-
trating monocyte-derived macrophages. Interestingly, research in
microglial senescence sheds light into the notion that microglial
degradation precedes neurodegeneration and perhaps neurode-
generation is a secondary factor to aging induced dysregulation of
microglial populations (59, 60).
Several studies of chronic inflammation in the CNS have
demonstrated a degree of immune infiltration into the CNS, which
is presumed to promote tissue remodeling as an attempt to main-
tain homeostasis (61, 62). The observed monocytic infiltration is
attributed to the breakdown and weakening of the blood–brain
barrier, which then facilitates the entrance of immune cells (63,
64). However, while monocyte infiltration has traditionally been
considered a late event in disease development recent studies by
Yamasaki et al. using an EAE model, demonstrated that infiltration
of Ly6C+ monocytes occurs at the onset of disease and that these
infiltrating cells are responsible for initiating nodal demyelination
(65). It was further demonstrated that, while infiltrating mono-
cytes are responsible for initiating nodal demyelination, resident
microglia are relatively quiescent upon disease onset (65–67). The
infiltrating monocytes promote disease progression though they
do not appear to contribute to the resident microglial population
(68). Similarly in a model of AD immune cell infiltration and
localization of microglial populations in areas of amyloid β (Aβ)
plaque deposits has been observed (69, 70).
Recently, researchers have been targeting microglial genes, such
as TGF-β activated kinase (TAK1) to elucidate how tissue-resident
macrophages are behaving during inflammation. While infiltrat-
ing monocytes are highly phagocytic and inflammatory, resident
microglia are relatively quiescent upon disease onset. However, a
recent study by Goldmann et al. demonstrated an essential role
of microglia in the onset and progression of disease in an EAE
model (71). By targeting TAK1 in microglia, but not periph-
eral monocytes/macrophages, they found that the lack of TAK1
in microglia inhibited the progression of inflammation in the
CNS, highlighting the contribution of both resident microglia
and bone marrow-derived monocytes in the onset and progres-
sion of EAE. However, in a model of EAE, infiltrating monocytes
are not maintained and do not appear to contribute to the resi-
dent microglial population (68). Furthermore, recent studies using
intravital correlated microscopy in zebrafish show that infiltrat-
ing phagocytes undergo cell death and are engulfed by resident
microglia during resolution of inflammation (72). Popovich et al.
investigated the potential for targeting CX3CR1 in a model of SCI
as the ligand–receptor interactions between CX3CR1 and CX3CL1
are fundamental for optimal microglial function (47). Further-
more, Donelly et al. presented two important findings, targeted
CX3CR1 deficiency/blocking in SCI results in enhanced recovery
and decreased monocytic infiltration to injury site (48).
ADIPOSE TISSUE MACROPHAGES
While it has long been clear that undernutrition can impair
immunocompetence, more recently, the progression of obesity
has also been attributed to a shift in immune function from an
M2 to M1 type responses (73). Work by both Spiegelman (74, 75)
and Lumeng et al. demonstrate critical interactions between adi-
pose tissue metabolism and the immune system, and the active
role of adipose tissue macrophage (ATM) polarization in the pro-
gression of obesity. Lean individuals in a non-inflammatory state
maintain a relatively low percentage (~10–15%) of resident ATMs
(76). Healthy adipose tissue consists of uniformly distributed alter-
natively activated M2 macrophages, expressing Arg1 and the cell
surface antigens CD206 and CD301 (Figure 3) (77–79). The M2
polarized state of the ATM population in healthy adipose tissue
is maintained by eosinophils (80), which secrete IL-4 (Figure 3)
(81, 82). Polarized M2 ATMs secrete interleukin-10 (IL-10), which
regulates glucose homeostasis within adipose tissue and systemic
tissues including muscle (Figure 3) (83). In turn adipose resi-
dent invariant natural killer T cells (iNKT), expressing nuclear
factor interleukin 3 regulated (E4BP4), induces the M2 pheno-
type through secretion of IL-10 (84). Healthy adipocytes, in turn,
secrete anti-inflammatory adipokines such as adiponectin, a hor-
mone that acts synergistically with IL-4 to exert anti-inflammatory
effects through the activation of AMP kinase (AMPK) and signal
transducer and activator of transcription 6 (STAT6), respectively
(78, 85, 86). The alternative M2 state is further sustained by
the transcriptional regulators peroxisome proliferator-activated
receptor-δ (PPARδ), PPARγ, and Krüppel-like factor 4 (KLF4) (82,
87–89).
The intimate interaction between adipocytes and ATMs may
reflect a common origin of these two cell types. Studies have
shown not only cross-talk between ATMs and adipocytes, but a
great deal of plasticity between these two lineages compartments
(90, 91). Furthermore, while still controversial (92) several stud-
ies have suggested that some adipocytes and adipose progenitors
may be hematopoietic stem cell-derived (93, 94). In addition,
Coussin et al. have shown that hematopoietic stem cells that can
reconstitute lethally irradiated recipient mice exist within adipose
tissue (95), and more recent studies have supported the concept
that adipose tissue is an extramedullary source of hematopoietic
stem/progenitor cells (96, 97). Yet other studies have demon-
strated the phagocytic capacity of pre-adipocytes and adipocytes
suggesting they can adopt macrophage-like functions (85, 98).
Interestingly, a recent study by Eto et al. has identified a novel
subpopulation of ATMs present in perivascular regions of adi-
pose tissue (99). This population of ATMs is characterized by the
expression of CD206 and the stem cell marker CD34. The investi-
gators further demonstrated that these cells can differentiate into
the adipogenic lineage in vitro, suggesting the possibility that this
subpopulation of ATMs might be a source of adipocytes in vivo.
Whether these cells are hematopoietic-derived or whether they
are precursors of the more abundant CD206+CD34− ATMs is
unclear.
In the late 2000s, Lumeng et al. identified adipose tissue inflam-
mation as an important early event in the development of obesity
related complications (82). At the onset of environmental and
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FIGURE 3 | Homeostatic regulation of ATM microenvironment.
Healthy adipose tissue contains a relatively low and uniformly dispersed
population of alternatively activated M2 macrophages, expressing cell
surface antigens CD206 and CD301. The M2 polarized state is maintained
by eosinophil and adipocyte derived adipokine secretions, IL-4, and
adiponectin, respectively. M2 ATMs maintain a homeostatic adipose
milieu with IL-10 secretions, which in turn regulate glucose homeostasis
within systemic tissues.
metabolic perturbation, such as chronic exposure to a high-fat
diet (HFD), adipose tissue undergoes vast biochemical and mor-
phological remodeling in part facilitated by infiltrating monocytes
that then differentiate into ATMs. An excess of nutrients stim-
ulates adipose tissue hyperplasia and hypertrophy as individual
adipocytes enlarge with excess triglycerides (TAGs) and simul-
taneously undergo heightened levels of cellular stress imparted
by endoplasmic reticular (ER) stress, hypoxia, release of excess
free fatty acids (FFAs), increased reactive oxygen species (ROS)
production, and adipocyte necrosis (77, 82, 100). The “stressed
adipocytes” create an environmental milieu that promotes a more
pro-inflammatory state exemplified with an increase in local IL-6,
TNFα, and IL-1 production (101). Early adipocyte death is facil-
itated by ATMs in an effort to maintain homeostasis, followed by
the development of a new range of pre-adipocytes (77, 102). Fur-
ther studies demonstrated that adipocyte necrosis is not only an
early event in diet-induced obesity (DIO), but it is a pivotal event,
which results in the release of chemokines that attract circulat-
ing monocytes to the site of inflammation (101, 103). It is well
established that throughout the course of adipose tissue inflam-
mation, the resident macrophage population increases from ~10
to 50–60% associated with a parallel increase in F4/80+CD11c+
inflammatory macrophages (78, 82). Interestingly, Kosteli et al.
demonstrated that weight loss also leads to a rapid recruitment
and accumulation of ATM’s in white adipose tissue (WAT) (104).
ATM accumulation occurs with lipolysis-induced release of exces-
sive FFAs and subsequent clearance of lipolysis byproducts by WAT
macrophages. Contrary to DIO ATM accumulation, weight loss
induced ATM recruitment does not exacerbate the existing inflam-
matory state and ATM populations diminish with the declining
rate of lipolysis (105).
At the onset of a physiological imbalance in the adipose
niche, such as weight gain, the uniformly dispersed small pop-
ulation of resident macrophages exhibits an alternatively activated
CD206+CD301+Arg1+ M2 phenotype (79, 82, 87). The ensu-
ing pro-inflammatory milieu created by stressed adipocytes and
necrosis attracts circulating monocytes to the site of inflam-
mation as early as 10 weeks from the onset of HFD introduc-
tion. Circulating Ly6C+/chemokine receptor-2 (CCR2)+ mono-
cytes are recruited and differentiate into the classically activated
CD11c+CD11b+F4/80+M1 ATMs expressing high levels of iNOS
and TNFα (78, 106). Cinti et al. demonstrated that the differenti-
ated M1 ATMs are exclusively localized in epididymal white adi-
pose tissue (eWAT) and not inguinal white adipose tissue (iWAT),
more specifically within “crown-like structures (CLS)” composed
of necrotic adipocytes (107). The authors incorporated a HSL−/−
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(hormone sensitive lipase KO) model to show that adipocyte
hypertrophy itself triggers a pro-inflammatory microenvironment
that facilitates infiltration of monocytes (107). The M1 monocyte-
derived macrophages are recruited and stabilized by CCR2 and
its ligand CCL2 in addition to other factors such as osteopontin
and fatty acids (FAs) (78, 106). CCL2 loss of function as well
as CCR2 gain of function or overexpression studies have col-
lectively illustrated the fundamental role of CCR2 and CCL2 in
recruitment and differentiation of macrophages with an M1 phe-
notype (78, 85). However, Amano et al. recently demonstrated
that local proliferation of ATMs contributes significantly to tissue
ATM accumulation. They further demonstrated that this in situ
proliferation is driven by monocyte chemotactic protein (MCP-1)
(108). These studies highlight the contribution of both local pro-
liferation and infiltrating monocytes to the accumulation of ATMs
in an obesity induced inflammatory state (108, 109).
While the observed ATM increase associated with obesity is
predominantly attributed to macrophages exhibiting an M1 phe-
notype, Shaul et al. recently suggested that there exists an M1/M2
hybrid ATM population and that the increase in ATMs with obesity
exhibit more of this mixed phenotype. The study noted an increase
in both M1 and M2 gene transcripts in a mouse DIO model
of chronic inflammation suggesting that perhaps both popula-
tions may influence the progression of obesity-associated chronic
inflammation (103). However, despite transcriptional increases in
both M1 and M2 genes, further studies by the authors demon-
strated an overall decrease in the M2 populations in the DIO model
as exhibited by flow cytometry analysis of eWAT cells express-
ing macrophage galactose type-C lectin-1 (MGL1, also known as
CD301). It is not clear whether this intermediate population of
ATMs represents a truly separate population of cells or whether
these ATMs represent a transitional population, resulting from the
inherent plasticity of ATM phenotypes in vivo.
In healthy adipose tissue, tissue remodeling is accompanied
by angiogenesis to maintain oxygen supply and critical nutrients
to promote adipose tissue homeostasis. However, under patho-
logical conditions, the existing adipocytes enlarge, angiogenesis
is limited, and tissue hypoxia ensues, resulting in the recruit-
ment of inflammatory cells. Angiogenesis is induced by vascular
endothelial factor-A (VEGF-A) stimulation of vascular endothelial
growth factor receptor-2 (VEGFR-2) (110, 111). WhenVEGFR-2 is
blocked early in the onset of obesity, the development of metabolic
disorders is elevated suggesting that expanding vascularization can
promote diet-induced disease (112). However, Elias et al. demon-
strated that overexpression of VEGF-A in adipose tissue in a DIO
model promotes the maintenance of a larger M2 population and
attenuates adipose tissue inflammation (113), coinciding with an
increase in local blood flow and decreased presence of necrotic
CLS. The authors further conclude that the correlative increase in
VEGF and M2 macrophage populations is likely due to recruit-
ment of M2 macrophages to sites of inflammation in adipose
tissue rather than promoting a phenotypic switch between M1 and
M2 macrophage populations. Recent studies also demonstrate an
increase in brown adipose tissue thermogenesis as a response to
cold, particularly in the presence of VEGF overexpression (113,
114). Interestingly, pivotal studies in by the Chawla lab demon-
strated that the absence of alternatively activated M2 macrophages
results in impaired metabolic adaptation to cold, while adminis-
tration of IL-4 promotes adaptation in a macrophage-dependent
manner (115), suggesting that the increased thermogenesis in
response to cold in the presence of VEGF could also be mediated,
at least in part, by M2 macrophages.
Therapeutic strategies in obesity and obesity-associated disease
may lie in understanding the molecular underpinnings of tissue-
resident macrophage heterogeneity. For instance, loss of KLF4
function has been associated with a loss of wound healing capaci-
ties under inflammatory conditions suggesting an important role
for KLF4 in maintaining an M2 phenotype in vivo (87). In addition
to KLF4, differential expression of PPARδ and PPARγ in current
experimental models, including HFD-induced obesity, illustrate
a critical role for activated PPARs in directing monocytic infil-
tration and polarization of macrophages toward the alternative
state in adipose tissue and liver (116, 117). Genetic deletion of
PPARδ and/or PPARγ in macrophages directs the differentiation of
monocytes toward a pro-inflammatory M1 phenotype (88, 118).
Conversely, agonist mediated PPAR-activation stimulates mono-
cytic differentiation into an alternately activated M2 phenotype
(119). These agonists include synthetic anti-diabetic agents such
as Thiazolidinediones (TZD) or natural agents such as abscisic
acid (ABA) (116, 119, 120). Recent studies by Satoh et al. have
demonstrated an essential role for the pseudokinase, Trib1, in
the development of M2-like macrophage populations. Mice lack-
ing Trib1 in the hematopoietic cell compartment exhibit a severe
reduction in M2-like macrophages in a number of tissues under
homeostatic conditions (121). In addition, these mice also exhibit
a significant reduction in eosinophils, suggesting that the defect
in M2 polarization could be, in part, secondary to diminished
levels of eosinophil-derived IL-4 under homeostatic conditions.
Importantly, these mice develop hypertriglyceridemia and insulin
resistance when maintained on a HFD, associated with increased
expression of pro-inflammatory cytokines (121, 122).
KUPFFER CELLS (LIVER-RESIDENT MACROPHAGES)
One of the largest resident populations of macrophages exists in
the liver. These YS macrophages, termed Kupffer cells, are posi-
tioned in the liver sinusoids where they efficiently clear microbes
and apoptotic cells from the portal circulation (Figure 4) (123).
While the proliferative capacity of hepatic macrophages remains
controversial, recent studies have suggested that Kupffer cells are
established prenatally and are maintained into adulthood inde-
pendent of replenishment from blood monocytes in a manner
dependent on M-CSF and GM-CSF (9). Kupffer cells also play
essential roles in tissue homeostasis, tissue remodeling, and reg-
ulation of metabolic function in the liver (Figure 4). Due to
their constant exposure to blood-borne food antigens and bac-
terial products of commensal intestinal flora, these cells are
also required to prevent the onset of inflammation in response
to these non-pathogenic stimuli (124). In contrast, monocyte-
derived macrophages in the liver play dual roles in promoting
both tissue inflammation and repair. These infiltrating cells are
initially CD11b+F4/80+ and eventually differentiate into more
mature CD11bloF4/80hi macrophages.
Following acute hepatic injury induced by acetaminophen,
there is a large influx of monocyte-derived macrophages induced
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FIGURE 4 |The dual role of M1/M2 Kupffer cells in NAFLD. Kupffer
cells play a pivotal role in host defense where they routinely clear
microbes and apoptotic bodies from portal circulation. During
diet-induced liver injury, tissue-resident macrophages exhibiting a
classically activated M1 phenotype predominate and secrete cytokines
that can alter hepatocyte lipid metabolism and induce MCP-1
dependent recruitment of monocytes into the liver. In turn, these
infiltrating cells facilitate the development and progression of NAFLD.
Restrained induction of M1 Kupffer cell apoptosis further perpetuates
liver inflammation.
by CCL2, accompanied by a significant decrease in the resident
population of Kupffer cells (125–127). This influx is blocked in
CCR2-deficient mice and these mice exhibit a delay in tissue recov-
ery indicating that the infiltrating population of macrophages
plays an important role in promoting liver repair following an
acute insult (126, 127). However, when both infiltrating hepatic
macrophages and resident Kupffer cells are depleted, tissue recov-
ery is dramatically impaired (126, 128). These mice exhibited
impaired clearance of necrotic cells and a defect in the restoration
of the liver microvasculature (126, 128). During the resolution
phase of acute inflammation, the infiltrating monocyte-derived
cells differentiate into the more mature reparative macrophages
and the resident Kupffer cell population is restored. Genomic
analysis of these co-existing populations of cells demonstrated
that, while the recovered Kupffer cell population was similar to
resident Kupffer cells before injury, these cells were distinct from
the resolution phase monocyte-derived liver macrophage popu-
lation, suggesting that these populations have distinct functions
in liver recovery from acute inflammation and that the infiltrat-
ing monocyte-derived macrophages do not replace the resident
Kupffer cells (126).
Non-alcoholic fatty liver disease is the most common liver dis-
ease in the western world, the prevalence of which has increased in
parallel to the increased incidence of obesity (129, 130). This clin-
icopathological condition is characterized by lipid accumulation
in hepatocytes and ranges from the non-progressive form termed
steatosis to non-alcoholic steatohepatitis (NASH), the progressive
form that is prone to the development of cirrhosis, liver cancer,
and liver failure (130, 131). In response to obesity, Kupffer cells are
engaged by cytokines, adipokines, and FAs secreted from adipose
tissue promoting a polarized M1 phenotype (132). In addition,
the release of FFAs into the liver by hypertrophic adipocytes leads
to hepatocyte ER stress and ROS production (132). Hepatocyte
death triggered by these responses results in the release of danger
associated molecular patterns (DAMPs) that further promote liver
macrophage polarization (123, 132).
In hepatic steatosis, pro-inflammatory cytokines produced by
M1 activated macrophages induce hepatic cholesterologenesis and
increase TAG production, resulting in discordant regulation of
lipid metabolism and homeostasis (Figure 4) (133–136). Sterol
regulatory element-binding proteins (SREBPs) directly activate
genes that mediate the synthesis and uptake of cholesterol and
FAs (137). Elevation of SREBPs often underlies the pathogenesis
of insulin resistance and type 2 diabetes (138, 139). In addition to
their initial propagation of fatty liver disease, activated M1 Kupf-
fer cells trigger the more severe form of non-alcoholic fatty liver
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disease (NAFLD), NASH. A recent study demonstrated that TNFα
produced by M1 hepatic macrophages increased intrahepatic
expression of MCP-1 (Figure 4), a major chemokine responsible
for CCR2-dependent recruitment of Ly6Chi monocytes (135). The
vast infiltration of Ly6Chi monocytes further perturbs liver home-
ostasis amplifying hepatic inflammatory responses (Figure 4).
The recruited monocyte-derived macrophage population also
plays a key role in promoting fibrogenesis. In mice deficient for
CCR2 or depleted of Kupffer cells, inflammatory cell infiltration,
steatohepatitis, and fibrosis are ameliorated (135).
Progression of NAFLD to NASH occurs in a subset of patients
with fatty liver disease, and this progression is largely linked to
the activation of toll like receptor 4 (TLR4) by both exogenous
and endogenous ligands. Bacteria and bacterial products, such as
LPS, which translocate from the gut can activate TLR4 signaling to
induce NASH (140, 141). Furthermore, endogenous high mobil-
ity group box-1 (HMGB-1) and FFAs have also been shown to be
endogenous ligands for TLR4 (142, 143). A number of recent stud-
ies have also demonstrated a crucial link between the composition
of gut microbiota, obesity, and the development of NASH (144).
CD14 promotes the activation of TLR4 by promoting the recruit-
ment of LPS to the TLR4 signaling complex (145). Interestingly,
Imajo et al. demonstrated that the increased levels of leptin asso-
ciated with obesity promotes the enhanced expression of CD14
in Kupffer cells, resulting in increased sensitivity of the Kupffer
cells to low doses of LPS (146). Translocated bacterial DNA has
also been shown to promote the development of NASH through
engagement of TLR9 in Kupffer cells, which stimulates the pro-
duction of interleukin-1β (IL-1β) (147). IL-1β in turn, promotes
hepatocyte lipid accumulation and death, as well inducing hepatic
stellate cells (HpSCs) to promote fibrosis.
Liver fibrosis is a common feature of chronic liver disease. It
is characterized by accumulation of extracellular matrix (ECM)
resulting from both increased synthesis and decreased degradation
of ECM proteins (148). During progressive liver injury, HpSC-
derived myofibroblast-like cells predominate and initiate collagen
deposition (148). Extensive evidence demonstrates a complex
interplay between Kupffer cells and HpSCs during hepatic fibro-
genesis. In general, alternatively activated M2 macrophages are
involved in tissue remodeling through the production of trans-
forming growth factor beta-1 (TGFβ-1), a potent inducer of the
HpSC fibrotic phenotype (149, 150). However, while arginase
produced by M2 cells during a Th2 response was thought to
play a role in progression of fibrosis, studies by Pesce et al.,
in which arginase is depleted in macrophages, highlight a role
for arginase-expressing macrophages in the resolution of fibro-
sis (151). Alternatively, in hepatic fibrosis, Ly6Chi inflammatory
monocyte-derived macrophages express higher levels of TGFβ-
1 and other pro-inflammatory cytokines that activate HpSCs
(152). TGFβ-1 not only promotes the fibrogenic activity of HpSCs
but also enhances expression of tissue inhibitors of metallopro-
teinases (TIMPs) by HpSCs that block the degradation of ECM.
These inflammatory monocyte-derived macrophages also exhibit
decreased expression of matrix metalloproteinases, thus directly
promoting fibrosis.
Interestingly, a recent report demonstrated a role for a novel
population of monocyte-derived macrophages in the resolution
of fibrosis. These cells are derived from Ly6Chi monocytes and
exhibit a CD11bhiF4/80intLy6Clo phenotype. These cells medi-
ate MMP-dependent degradation of the ECM and the expres-
sion profile of this population of resolving monocyte-derived
macrophages demonstrates that these cells are distinct from the
typical M1/M2 populations of macrophages (152). More recently,
it has been reported that alternatively activated M2 Kupffer cells
can promote caspase-3-dependent apoptosis of classically acti-
vated M1 Kupffer cells, thus providing a protective mechanism
against NAFLD (Figure 4) (153). The M2 mediated apoptosis of
M1 Kupffer cells was shown to be arginase dependent by way of
IL-10 (153). Interestingly, alternatively activated M2 Kupffer cells
limit hepatocyte apoptosis and steatosis in alcohol induced liver
injury through the release of IL-6, a mechanism that may expand
to NAFLD (154).
SUMMARY
Based on recent studies, a unifying theme is beginning to emerge
between the contribution of tissue-resident macrophages and
infiltrating monocyte-derived macrophages in chronic inflam-
mation (Figure 5). (1) Both microglia and Kupffer cells are of
embryonic origin. Microglia are YS, while contribution of yolk
sac and fetal liver has been described for Kupffer cells. However,
because it now appears that the yolk sac progenitors seed the liver
where they continue to contribute to tissue-resident macrophage
populations independent of hematopoietic stem cells, it is likely
that these cells share a common progenitor and are ontologically
indistinguishable. (2) In the brain and liver, resident macrophages
and infiltrating monocyte-derived macrophages play distinct roles
in the progression of inflammation. In the brain, microglia are
required for the initiation of disease, while infiltrating monocyte-
derived macrophages promote demyelination. In the liver, both
resident and infiltrating populations contribute to both inflam-
mation and repair, Kupffer cells are largely responsible for the
development of fibrosis. (3) In the brain and liver, infiltrating
monocytes do not contribute to the resident macrophage pool
rather, during recovery, resident cells are replenished through
local proliferation. (4) In both the brain and liver, there is
evidence that the resident population of macrophages plays a
role in promoting apoptosis and/or clearance of the infiltrating
monocyte-derived macrophage population during the recovery
phase.
However, the relative contribution of resident versus infil-
trating populations of macrophages in adipose tissue remains
obscure. While ATMs are generally considered to be hematopoi-
etic stem cells-derived, this assumption is based on studies using
myeloablation. Further fate mapping studies will be needed to
definitively identify the origin of ATMs. In addition, while it
is clear that both infiltration of monocytes and proliferation
of resident macrophage contribute to the massive expansion of
ATMs in obesity, the respective roles of resident versus infiltrating
macrophages in the propagation and/or resolution of inflamma-
tion is unclear. Finally, it unknown whether infiltrating monocyte-
derived macrophages in adipose tissue ultimately contribute to the
resident population.
In all cases, the M1/M2 polarization of macrophages in inflam-
mation and disease resolution has been described. However, these
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FIGURE 5 | Resident macrophage populations in steady state and
inflammation. Resident microglia and Kupffer cell populations, both yolk
sac-derived, are maintained through self-renewal, unlike macrophages
resident to the adipose tissue, which are thought to originate from circulating
blood monocytes (MO). Although the progression of tissue specific
pathophysiological insults are dependent on both resident and infiltrating
macrophages, monocyte-derived macrophages do not replenish resident
microglia and Kupffer cell populations.
are largely based on studies that do not distinguish between resi-
dent macrophage and infiltrating macrophage populations. Given
the emergence of technologies that help to distinguish resident
cells from infiltrating cells, it will be essential to re-visit the M1/M2
paradigm in the context of macrophage ontogeny to determine the
extent of plasticity of individual populations of macrophages.
The recognition that the M1/M2 polarization of macrophages
plays a central role in the progression of chronic inflammation in a
wide range of diseases and that therapeutic approaches to chronic
inflammatory disease could involve the regulation of macrophage
polarization renders these outstanding questions highly signifi-
cant. Taking into consideration not only the polarization state
of macrophages, but also their ontogeny and phenotypic plastic-
ity, will be central in the development of therapeutic approaches
for the treatment of chronic inflammatory disease aimed at
redirecting macrophage polarization and function.
REFERENCES
1. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, et al. Gene-
expression profiles and transcriptional regulatory pathways that underlie the
identity and diversity of mouse tissue macrophages. Nat Immunol (2012)
13:1118–28. doi:10.1038/ni.2419
2. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat
Immunol (2013) 14:986–95. doi:10.1038/ni.2705
3. Chow A,Huggins M,Ahmed J,Hashimoto D,KunisakiY,Pinho S,et al. CD169+
macrophages provide a niche promoting erythropoiesis under homeostasis,
myeloablation and in JAK2V617F-induced polycythemia vera. Nat Med (2014)
19:429–36. doi:10.1038/nm.3057
4. Haldar M, Kohyama M, So AY-L, Kc W, Wu X, Briseño CG, et al. Heme-
mediated SPI-C induction promotes monocyte differentiation into iron-
recycling macrophages. Cell (2014) 156:1223–34. doi:10.1016/j.cell.2014.01.
069
5. Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue
macrophages. Immunity (2014) 41:21–35. doi:10.1016/j.immuni.2014.06.013
6. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, home-
ostasis and disease. Nature (2013) 496:445–55. doi:10.1038/nature12034
7. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate map-
ping analysis reveals that adult microglia derive from primitive macrophages.
Science (2010) 330:841–5. doi:10.1126/science.1194637
8. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kier-
dorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic
stem cells. Science (2012) 336:86–90. doi:10.1126/science.1219179
9. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping
reveals origins and dynamics of monocytes and tissue macrophages under
homeostasis. Immunity (2014) 38:79–91. doi:10.1016/j.immuni.2012.12.001
10. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, et al.
Embryonic and adult-derived resident cardiac macrophages are maintained
www.frontiersin.org January 2015 | Volume 5 | Article 683 | 11
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dey et al. Macrophage ontogeny and polarization
through distinct mechanisms at steady state and during inflammation. Immu-
nity (2014) 40:91–104. doi:10.1016/j.immuni.2013.11.019
11. Heidt T, Courties G, Dutta P, Sager HB, Sebas M, Iwamoto Y, et al. Dif-
ferential contribution of monocytes to heart macrophages in steady-state
and after myocardial infarction. Circ Res (2014) 115:284–95. doi:10.1161/
CIRCRESAHA.115.303567
12. Pinto AR, Godwin JW, Rosenthal NA. Macrophages in cardiac homeosta-
sis, injury responses and progenitor cell mobilisation. Stem Cell Res (2014)
13:705–14. doi:10.1016/j.scr.2014.06.004
13. Hashimoto D, Chow A, Noizat C, Teo P, Beth M, Leboeuf M, et al. Tis-
sue resident macrophages self-maintain locally throughout adult life with
minimal contribution from circulating monocytes. Immunity (2014) 38:1–25.
doi:10.1016/j.immuni.2013.04.004
14. Bogunovic M, Ginhoux F, Helft J, Shang L, Greter M, Liu K, et al. Origin of
the lamina propria dendritic cell network Milena. Immunity (2010) 31:513–25.
doi:10.1016/j.immuni.2009.08.010
15. Varol C,Vallon-Eberhard A,Elinav E,Aychek T,ShapiraY,Luche H,et al. Intesti-
nal lamina propria dendritic cell subsets have different origin and functions.
Immunity (2009) 31:502–12. doi:10.1016/j.immuni.2009.06.025
16. Perdiguero EG, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al.
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid
progenitors. Nature (2014). doi:10.1038/nature13989
17. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen
N, et al. Local macrophage proliferation, rather than recruitment from the
blood, is a signature of TH2 inflammation. Science (2011) 332:1284–8.
doi:10.1126/science.1204351
18. Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, Duncan S, Brombacher F,
et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond
homeostatic levels controlled by CSF-1. J Exp Med (2013) 210:2477–91.
doi:10.1084/jem.20121999
19. Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL,
et al. Langerhans cell homeostasis and turnover after nonmyeloablative and
myeloablative allogeneic hematopoietic cell transplantation. Transplantation
(2014) 98:563–8. doi:10.1097/TP.0000000000000097
20. Cohen HB, Mosser DM. Cardiac macrophages: how to mend a broken heart.
Immunity (2014) 40:3–5. doi:10.1016/j.immuni.2013.12.005
21. Rosas M, Davies LC, Giles PJ, Liao C-T, Kharfan B, Stone TC, et al. The tran-
scription factor Gata6 links tissue macrophage phenotype and proliferative
renewal. Science (2014) 344:645–8. doi:10.1126/science.1251414
22. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program
of localization and functional polarization of macrophages. Cell (2014)
157:832–44. doi:10.1016/j.cell.2014.04.016
23. Schneider C, Nobs SP, Kurrer M, Rehrauer H, Thiele C, Kopf M. Induction of
the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differ-
entiation of fetal monocytes into alveolar macrophages. Nat Immunol (2014)
15:1026–37. doi:10.1038/ni.3005
24. A-gonzalez N, Guillen JA, Gallardo G, Diaz M, Rosa JV, De Hernandez IH, et al.
The nuclear receptor LXRα controls the functional specialization of splenic
macrophages. Nat Immunol (2014) 14:831–9. doi:10.1038/ni.2622
25. Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoff-
mann R, et al. Comparison of gene expression profiles between human and
mouse monocyte subsets. Blood (2010) 115:e10–9. doi:10.1182/blood-2009-
07-235028
26. Cros J, Cagnard N, Woollard K, Patey N, Zhang S-Y, Senechal B, et al. Human
CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and
TLR8 receptors. Immunity (2010) 33:375–86. doi:10.1016/j.immuni.2010.08.
012
27. Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE,
et al. Minimal differentiation of classical monocytes as they survey steady-state
tissues and transport antigen to lymph nodes. Immunity (2013) 39:599–610.
doi:10.1016/j.immuni.2013.08.007
28. Mills CD, Thomas AC, Lenz LL, Munder M. Macrophage: SHIP of immunity.
Front Immunol (2014) 5:1–5. doi:10.3389/fimmu.2014.00620
29. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages
and the Th1/Th2 paradigm. J Immunol (2000) 164:6166–73. doi:10.4049/
jimmunol.164.12.6166
30. Mills CD, Ley K. M1 and M2 macrophages: the chicken and the egg of immu-
nity. J Innate Immune (2014) 6:1716–26. doi:10.1159/000364945
31. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al.
Macrophage activation and polarization: nomenclature and experimental
guidelines. Immunity (2014) 41:14–20. doi:10.1016/j.immuni.2014.06.008
32. Perry VH, Teeling J. Microglia and macrophages of the central nervous sys-
tem: the contribution of microglia priming and systemic inflammation to
chronic neurodegeneration. Semin Immunopathol (2013) 35:601–12. doi:10.
1007/s00281-013-0382-8
33. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and
tissue homeostasis. Nat Rev Immunol (2014) 14:392–404. doi:10.1038/nri3671
34. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG,
et al. Microglia emerge from erythromyeloid precursors via Pu.1- and
Irf8-dependent pathways. Nat Neurosci (2013) 16:273–80. doi:10.1038/nn.
3318
35. Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, et al. Stroma-
derived interleukin-34 controls the development and maintenance of langer-
hans cells and the maintenance of microglia. Immunity (2012) 37:1050–60.
doi:10.1016/j.immuni.2012.11.001
36. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, et al. IL-34 is a
tissue-restricted ligand of CSF1R required for the development of Langerhans
cells and microglia. Nat Immunol (2012) 13:753–60. doi:10.1038/ni.2360
37. Miron VE, Franklin RJM. Macrophages and CNS remyelination. J Neurochem
(2014) 130:165–71. doi:10.1111/jnc.12705
38. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FMV. Local self-renewal can
sustain CNS microglia maintenance and function throughout adult life. Nat
Neurosci (2007) 10:1538–43. doi:10.1038/nn2014
39. Olah M, Biber K, Vinet J, Boddeke HWGM. Microglia phenotype diver-
sity. CNS Neurol Disord Drug Targets (2011) 10:108–18. doi:10.2174/
187152711794488575
40. Eggen BJL, Raj D, Hanisch U-K, Boddeke HWGM. Microglial phenotype and
adaptation. J Neuroimmune Pharmacol (2013) 8:807–23. doi:10.1007/s11481-
013-9490-4
41. Kettenmann H, Hanisch U, Noda M, Verkhratsky A. Physiology of microglia.
Physiol Rev (2011) 91:461–553. doi:10.1152/physrev.00011.2010
42. Boche D, Perry VH, Nicoll JAR. Review: activation patterns of microglia and
their identification in the human brain. Neuropathal Appl Neurobiol (2013)
39:3–18. doi:10.1111/nan.12011
43. Prinz M, Tay TL, Wolf Y, Jung S. Microglia: unique and common fea-
tures with other tissue macrophages. Acta Neuropathol (2014) 128:319–31.
doi:10.1007/s00401-014-1267-1
44. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Amanda J, Gabriely G,
et al. Identification of a unique TGF-β dependent molecular and functional
signature in microglia. Nat Neurosci (2014) 17:131–43. doi:10.1038/nn.3599
45. Prinz M, Priller J. Microglia and brain macrophages in the molecular age:
from origin to neuropsychiatric disease. Nat Rev Neurosci (2014) 15:300–12.
doi:10.1038/nrn3722
46. Landsman L, Bar-On L, Zernecke A, Kim K-W, Krauthgamer R, Shagdarsuren
E, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by
promoting cell survival. Blood (2009) 113:963–72. doi:10.1182/blood-2008-
07-170787
47. Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, et al.
Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury
by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J
Neurosci (2011) 31:9910–22. doi:10.1523/JNEUROSCI.2114-11.2011
48. Wolf Y, Yona S, Kim K-W, Jung S. Microglia, seen from the CX3CR1 angle.
Front Cell Neurosci (2013) 7:26. doi:10.3389/fncel.2013.00026
49. Billadeau DD, Leibson PJ. ITAMs versus ITIMs: striking a balance during cell
regulation. J Clin Invest (2002) 109:161–8. doi:10.1172/JCI200214843
50. Linnartz B, Neumann H. Microglial activatory (immunoreceptor tyrosine-
based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhi-
bition motif)-signaling receptors for recognition of the neuronal glycocalyx.
Glia (2013) 61:37–46. doi:10.1002/glia.22359
51. Lambertsen KL, Deierborg T, Gregersen R, Clausen BH, Wirenfeldt M, Nielsen
HH, et al. Differences in origin of reactive microglia in bone marrow chimeric
mouse and rat after transient global ischemia. J Neuropathol Exp Neurol (2011)
70:481–94. doi:10.1097/NEN.0b013e31821db3aa
52. Bechmann I, Priller J, Kovac A, Böntert M, Wehner T, Klett FF, et al. Immune
surveillance of mouse brain perivascular spaces by blood-borne macrophages.
Eur J Neurosci (2001) 14:1651–8. doi:10.1046/j.0953-816x.2001.01793.x
Frontiers in Immunology | Molecular Innate Immunity January 2015 | Volume 5 | Article 683 | 12
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dey et al. Macrophage ontogeny and polarization
53. Cherry JD, Olschowka JA, O’Banion MK. Neuroinflammation and M2
microglia: the good, the bad, and the inflamed. J Neuroinflammation (2014)
11:98. doi:10.1186/1742-2094-11-98
54. Varnum MM, Ikezu T. The classification of microglial activation
phenotypes on neurodegeneration and regeneration in Alzheimer’s disease
brain. Arch Immunol Ther Exp (2012) 60:251–66. doi:10.1007/s00005-012-
0181-2
55. Amor S, Peferoen LAN, Vogel DYS, Breur M, van der Valk P, Baker D, et al.
Inflammation in neurodegenerative diseases – an update. Immunology (2014)
142:151–66. doi:10.1111/imm.12233
56. Walker FR, Beynon SB, Jones KA, Zhao Z, Kongsui R, Cairns M, et al. Dynamic
structural remodelling of microglia in health and disease: a review of the
models, the signals and the mechanisms. Brain Behav Immun (2014) 37:1–14.
doi:10.1016/j.bbi.2013.12.010
57. Eggen BJL, Raj D, Hanisch U. Microglial phenotype and adaptation. J Neu-
roimmune Pharmacol (2013) 8:807–23. doi:10.1007/s11481-013-9490-4
58. Crain JM, Nikodemova M, Watters JJ. Microglia express distinct M1 and M2
phenotypic markers in the postnatal and adult central nervous system in male
and female mice. J Neurosci Res (2013) 91:1143–51. doi:10.1002/jnr.23242
59. Streit WJ, Conde JR. Microglia in the aging brain. J Neuropathol Exp Neurol
(2006) 65:199–203. doi:10.1097/01.jnen.0000202887.22082.63
60. Streit WJ, Xue Q-S. Microglial senescence. CNS Neurol Disord Drug Targets
(2013) 12:763–7. doi:10.2174/18715273113126660176
61. Rezai-Zadeh K, Gate D, Town T. CNS infiltration of peripheral immune
cells: d-day for neurodegenerative disease? J Neuroimmune Pharmacol (2009)
4:462–75. doi:10.1007/s11481-009-9166-2
62. Jiang Z, Jiang JX, Zhang G-X. Macrophages: a double-edged sword in exper-
imental autoimmune encephalomyelitis. Immunol Lett (2014) 160:17–22.
doi:10.1016/j.imlet.2014.03.006
63. Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, Mat-
lock BK, et al. Obesity induced by a high-fat diet is associated with increased
immune cell entry into the central nervous system. Brain Behav Immun (2014)
35:33–42. doi:10.1016/j.bbi.2013.06.007
64. Tucsek Z, Toth P, Sosnowska D, Gautam T, Mitschelen M, Koller A, et al. Obe-
sity in aging exacerbates blood-brain barrier disruption, neuroinflammation,
and oxidative stress in the mouse hippocampus: effects on expression of genes
involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol A Biol
Sci Med Sci (2013) 69:1212–26. doi:10.1093/gerona/glt177
65. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, et al. Differential
roles of microglia and monocytes in the inflamed central nervous system. J Exp
Med (2014) 211:1533–49. doi:10.1084/jem.20132477
66. Jung S, Schwartz M. Non-identical twins – microglia and monocyte-derived
macrophages in acute injury and autoimmune inflammation. Front Immunol
(2012) 3:89. doi:10.3389/fimmu.2012.00089
67. Vainchtein ID, Vinet J, Brouwer N, Brendecke S, Biagini G, Biber K, et al. In
acute experimental autoimmune encephalomyelitis, infiltrating macrophages
are immune activated, whereas microglia remain immune suppressed. Glia
(2014) 62:1724–35. doi:10.1002/glia.22711
68. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FMV. Infiltrating mono-
cytes trigger EAE progression, but do not contribute to the resident microglia
pool. Nat Neurosci (2011) 14:1142–9. doi:10.1038/nn.2887
69. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres
M, Sanchez-Varo R, et al. Inflammatory response in the hippocampus of
PS1M146L/APP751SL mouse model of Alzheimer’s disease: age-dependent
switch in the microglial phenotype from alternative to classic. J Neurosci (2008)
28:11650–61. doi:10.1523/JNEUROSCI.3024-08.2008
70. Yi C-X, Tschöp MH, Woods SC, Hofmann SM. High-fat-diet exposure
induces IgG accumulation in hypothalamic microglia. Dis Model Mech (2012)
5:686–90. doi:10.1242/dmm.009464
71. Goldmann T, Wieghofer P, Müller PF, Wolf Y, Varol D, Yona S, et al. A new type
of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune
inflammation. Nat Neurosci (2013) 16:1618–26. doi:10.1038/nn.3531
72. Van Ham TJ, Brady CA, Kalicharan RD, Oosterhof N, Kuipers J, Veenstra-Algra
A, et al. Intravital correlated microscopy reveals differential macrophage and
microglial dynamics during resolution of neuroinflammation. Dis Model Mech
(2014) 7:857–69. doi:10.1242/dmm.014886
73. De Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation
and the immune system. Proc Nutr Soc (2012) 71:332–8. doi:10.1017/
S0029665112000092
74. Hotamisligil GS, Shargill S, Spiegelman BM. Adipose expression of tumor
necrosis factor – a: direct role in obesity-linked insulin resistance. Science
(1993) 259:87–91. doi:10.1126/science.7678183
75. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P. Regula-
tion of adipocyte gene expression in differentiation and syndromes of obe-
sity/diabetes. J Biol Chem (1993) 268:6823–6.
76. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune
cells: key players in immunometabolism. Trends Endocrinol Metab (2012)
23:407–15. doi:10.1016/j.tem.2012.05.011
77. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang
ZV, et al. Adipocyte inflammation is essential for healthy adipose tissue expan-
sion and remodeling. Cell Metab (2014) 20:103–18. doi:10.1016/j.cmet.2014.
05.005
78. Chawla A, Nguyen KD, Goh YPS. Macrophage-mediated inflammation in
metabolic disease. Nat Rev Immunol (2011) 11:738–49. doi:10.1038/nri3071
79. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of
adipose tissue macrophages with obesity is generated by spatiotemporal dif-
ferences in macrophage subtypes. Diabetes (2008) 57:3239–46. doi:10.2337/
db08-0872
80. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK,
et al. Eosinophils sustain adipose alternatively activated macrophages associ-
ated with glucose homeostasis. Science (2011) 332:243–7. doi:10.1126/science.
1201475
81. Prajeeth CK, Löhr K, Floess S, Zimmermann J, Ulrich R, Gudi V, et al. Effector
molecules released by Th1 but not Th17 cells drive an M1 response in microglia.
Brain Behav Immun (2014) 37:248–59. doi:10.1016/j.bbi.2014.01.001
82. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch
in adipose tissue macrophage polarization. J Clin Invest (2007) 117:175–84.
doi:10.1172/JCI29881
83. Nagareddy PR, Kraakman M, Masters SL, Stirzaker RA, Gorman DJ, Grant RW,
et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in
obesity. Cell Metab (2014) 19:821–35. doi:10.1016/j.cmet.2014.03.029
84. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, et al. Regu-
latory iNKT cells lack expression of the transcription factor PLZF and control
the homeostasis of Treg cells and macrophages in adipose tissue. Nat Immunol
(2014) 16:85–95. doi:10.1038/ni.3047
85. Gustafson B, Hammarstedt A,Andersson CX, Smith U. Inflamed adipose tissue:
a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler
Thromb Vasc Biol (2007) 27:2276–83. doi:10.1161/ATVBAHA.107.147835
86. Steinberg GR, Schertzer JD. AMPK promotes macrophage fatty acid oxidative
metabolism to mitigate inflammation: implications for diabetes and cardio-
vascular disease. Immunol Cell Biol (2014) 92:340–5. doi:10.1038/icb.2014.11
87. Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, et al. Krüppel-like fac-
tor 4 regulates macrophage polarization. J Clin Invest (2011) 121:2736–49.
doi:10.1172/JCI45444
88. Chawla A. Control of macrophage activation and function by PPARs. Circ Res
(2010) 106:1559–69. doi:10.1161/CIRCRESAHA.110.216523
89. Fernández-Quintela A, Churruca I, Portillo MP. The role of dietary fat in adi-
pose tissue metabolism. Public Health Nutr (2007) 10:1126–31. doi:10.1017/
S1368980007000602
90. Charrière G, Cousin B, Arnaud E, André M, Bacou F, Penicaud L, et al.
Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem
(2003) 278:9850–5. doi:10.1074/jbc.M210811200
91. Chazenbalk G, Bertolotto C, Heneidi S, Jumabay M, Trivax B, Aronowitz J,
et al. Novel pathway of adipogenesis through cross-talk between adipose tis-
sue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity.
PLoS One (2011) 6:e17834. doi:10.1371/journal.pone.0017834
92. Koh YJ, Kang S, Lee HJ, Choi T-S, Lee HS, Cho C-H, et al. Bone marrow-derived
circulating progenitor cells fail to transdifferentiate into adipocytes in adult adi-
pose tissues in mice. J Clin Invest (2007) 117:3684–95. doi:10.1172/JCI32504
93. Sera Y, Larue AC, Moussa O, Mehrotra M, James D, Williams CR, et al.
Hematpoietic stem cell origin of adipocytes. Exp Hematol (2010) 37:1108–20.
doi:10.1016/j.exphem.2009.06.008
94. Crossno JT, Majka SM, Grazia T, Gill RG, Klemm DJ. Rosiglitazone promotes
development of a novel adipocyte population from bone marrow-derived
circulating progenitor cells. J Clin Invest (2006) 116:3220–8. doi:10.1172/
JCI28510
95. Luche E, Cousin B, Garidou L, Serino M, Waget A, Barreau C, et al. Meta-
bolic endotoxemia directly increases the proliferation of adipocyte precursors
www.frontiersin.org January 2015 | Volume 5 | Article 683 | 13
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dey et al. Macrophage ontogeny and polarization
at the onset of metabolic diseases through a CD14-dependent mechanism. Mol
Metab (2013) 2:281–91. doi:10.1016/j.molmet.2013.06.005
96. Poglio S, De Toni-Costes F, Arnaud E, Laharrague P, Espinosa E, Casteilla L,
et al. Adipose tissue as a dedicated reservoir of functional mast cell progenitors.
Stem Cells (2010) 28:2065–72. doi:10.1002/stem.523
97. Han J, Koh YJ, Moon HR, Ryoo HG, Cho C-H, Kim I, et al. Adipose tissue is
an extramedullary reservoir for functional hematopoietic stem and progenitor
cells. Blood (2010) 115:957–64. doi:10.1182/blood-2009-05-219923
98. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, et al. A role
for preadipocytes as macrophage-like cells. FASEB J (1999) 13:305–12.
99. Eto H, Ishimine H, Kinoshita K, Watanabe-Susaki K, Kato H, Doi K, et al.
Characterization of human adipose tissue-resident hematopoietic cell popu-
lations reveals a novel macrophage subpopulation with CD34 expression and
mesenchymal multipotency. Stem Cells Dev (2013) 22:985–97. doi:10.1089/
scd.2012.0442
100. Manteiga S, Choi K, Jayaraman A, Lee K. Systems biology of adipose tissue
metabolism: regulation of growth, signaling and inflammation. Wiley Interdis-
cip Rev Syst Biol Med (2013) 5:425–47. doi:10.1002/wsbm.1213
101. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, Defuria J, Jick Z, et al.
Adipocyte death, adipose tissue remodeling, and obesity complications. Dia-
betes (2007) 56:2910–8. doi:10.2337/db07-0767
102. Lee Y, Thacker RI, Hall BE, Kong R, Granneman JG. Exploring the activated
adipogenic niche. Cell Cycle (2014) 13:184–90. doi:10.4161/cc.27647
103. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS. Dynamic, M2-Like
remodeling phenotypes of CD11c+ adipose tissue macrophages during high-
fat diet-induced obesity in mice. Diabetes (2010) 59:1171–81. doi:10.2337/
db09-1402
104. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, et al. Weight loss
and lipolysis promote a dynamic immune response in murine adipose tissue.
J Clin Invest (2010) 120:3466–79. doi:10.1172/JCI42845
105. Red Eagle A, Chawla A. In obesity and weight loss, all roads lead to the mighty
macrophage. J Clin Invest (2010) 120:3437–40. doi:10.1172/JCI44721
106. Chávez-Sánchez L, Espinosa-Luna JE, Chávez-Rueda K, Legorreta-Haquet MV,
Montoya-Díaz E, Blanco-Favela F. Innate immune system cells in atheroscle-
rosis. Arch Med Res (2014) 45:1–14. doi:10.1016/j.arcmed.2013.11.007
107. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte
death defines macrophage localization and function in adipose tissue of obese
mice and humans. J Lipid Res (2005) 46:2347–55. doi:10.1194/jlr.M500294-
JLR200
108. Amano SU, Cohen JL, Vangala P, Tencerova M, Nicoloro SM, Yawe JC, et al.
Local proliferation of macrophages contributes to obesity-associated adipose
tissue inflammation. Cell Metab (2014) 19:162–71. doi:10.1016/j.cmet.2013.
11.017
109. Haase J, Weyer U, Immig K, Klöting N, Blüher M, Eilers J, et al. Local prolifer-
ation of macrophages in adipose tissue during obesity-induced inflammation.
Diabetologia (2014) 57:562–71. doi:10.1007/s00125-013-3139-y
110. Shibuya M. Vascular endothelial growth factor and its receptor system: phys-
iological functions in angiogenesis and pathological roles in various diseases.
J Biochem (2013) 153:13–9. doi:10.1093/jb/mvs136
111. Moens S, Goveia J, Stapor PC, Cantelmo AR, Carmeliet P. The multifaceted
activity of VEGF in angiogenesis – implications for therapy responses. Cytokine
Growth Factor Rev (2014) 25:473–82. doi:10.1016/j.cytogfr.2014.07.009
112. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity.
J Clin Invest (2011) 121:2094–101. doi:10.1172/JCI45887
113. Elias I, Franckhauser S, Ferré T, Vilà L, Tafuro S, Muñoz S, et al. Adipose
tissue overexpression of vascular endothelial growth factor protects against
diet-induced obesity and insulin resistance. Diabetes (2012) 61:1801–13.
doi:10.2337/db11-0832
114. Sun K, Kusminski CM, Luby-Phelps K, Spurgin SB, An YA, Wang QA, et al.
Brown adipose tissue derived VEGF-A modulates cold tolerance and energy
expenditure. Mol Metab (2014) 3:474–83. doi:10.1016/j.molmet.2014.03.010
115. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively acti-
vated macrophages produce catecholamines to sustain adaptive thermogenesis.
Nature (2012) 480:104–8. doi:10.1038/nature10653
116. Bassaganya-Riera J, Misyak S, Guri AJ, Hontecillas R. PPAR gamma is highly
expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue
inflammation. Cell Immunol (2009) 258:138–46. doi:10.1016/j.cellimm.2009.
04.003
117. Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, Müller M. Perox-
isome proliferator-activated receptor gamma activation promotes infiltration
of alternatively activated macrophages into adipose tissue. J Biol Chem (2008)
283:22620–7. doi:10.1074/jbc.M710314200
118. Odegaard JI, Ricardo-gonzalez RR, Goforth MH, Christine R, Subramanian
V, Mukundan L, et al. Macrophage-specific PPARgamma controls alterna-
tive activation and improves insulin resistance. Nature (2008) 447:1116–20.
doi:10.1038/nature05894
119. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S,
et al. PPARgamma activation primes human monocytes into alternative M2
macrophages with anti-inflammatory properties. Cell Metab (2007) 6:137–43.
doi:10.1016/j.cmet.2007.06.010
120. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid synergizes with rosigli-
tazone to improve glucose tolerance, down-modulate macrophage accumula-
tion in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis. Clin Nutr
(2011) 29:646–53. doi:10.1016/j.clnu.2010.02.003
121. Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, et al.
Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages.
Nature (2013) 495:524–8. doi:10.1038/nature11930
122. Akira S, Misawa T, Satoh T, Saitoh T. Macrophages control innate inflamma-
tion. Diabetes Obes Metab (2013) 15(Suppl 3):10–8. doi:10.1111/dom.12151
123. Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and polarization in
liver homeostasis and pathology. Hepatology (2014) 59:2034–42. doi:10.1002/
hep.26754
124. Balmer ML, Slack E, de Gottardi A, Lawson MAE, Hapfelmeier S, Miele
L, et al. The liver may act as a firewall mediating mutualism between the
host and its gut commensal microbiota. Sci Transl Med (2014) 6:237ra66.
doi:10.1126/scitranslmed.3008618
125. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL. Role of CCR2 in
macrophage migration into the liver during acetaminophen-induced hepato-
toxicity in the mouse. Hepatology (2002) 35:1093–103. doi:10.1053/jhep.2002.
33162
126. Zigmond E, Samia-Grinberg S, Pasmanik-Chor M, Brazowski E, Shibolet O,
Halpern Z, et al. Infiltrating monocyte-derived macrophages and resident
Kupffer cells display different ontogeny and functions in acute liver injury.
J Immunol (2014) 193:344–53. doi:10.4049/jimmunol.1400574
127. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH. Liver myofi-
broblasts regulate infiltration and positioning of lymphocytes in human liver.
Gastroenterology (2009) 136:705–14. doi:10.1053/j.gastro.2008.10.020
128. You Q, Holt M, Yin H, Li G, Hu C-J, Ju C. Role of hepatic resident and infiltrat-
ing macrophages in liver repair after acute injury. Biochem Pharmacol (2013)
86:836–43. doi:10.1016/j.bcp.2013.07.006
129. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver
disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol
l (2007) 22:293–303. doi:10.1111/j.1440-1746.2007.04824.x
130. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol
Hepatol (2013) 10:686–90. doi:10.1038/nrgastro.2013.171
131. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat
Rev Gastroenterol Hepatol (2013) 10:656–65. doi:10.1038/nrgastro.2013.183
132. Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol (2014)
56:704–13. doi:10.1016/j.jhep.2011.09.020
133. Endo M, Masaki T, Seike M, Yoshimatsu H. TNF-a induces hepatic steatosis
in mice by enhancing gene expression of sterol regulatory element binding
protein-1c. Exp Biol Med (2007) 232:614–21.
134. Pandey AK, Munjal N, Datta M. Gene expression profiling and network
analysis reveals lipid and steroid metabolism to be the most favored by TNFal-
pha in HepG2 cells. PLoS One (2010) 5:e9063. doi:10.1371/journal.pone.
0009063
135. Tosello-Trampont A-C, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS.
Kupffer cells trigger nonalcoholic steatohepatitis development in diet-induced
mouse model through tumor necrosis factor-α production. J Biol Chem (2012)
287:40161–72. doi:10.1074/jbc.M112.417014
136. Musso G, Gambino R, Cassader M. Cholesterol metabolism and the patho-
genesis of non-alcoholic steatohepatitis. Prog Lipid Res (2013) 52:175–91.
doi:10.1016/j.plipres.2012.11.002
137. Jeon T-I, Osborne TF. SREBPs: metabolic integrators in physiology and metab-
olism. Trends Endocrinol Metab (2012) 23:65–72. doi:10.1016/j.tem.2011.10.
004
Frontiers in Immunology | Molecular Innate Immunity January 2015 | Volume 5 | Article 683 | 14
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dey et al. Macrophage ontogeny and polarization
138. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein
JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance
and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell (2000)
6:77–86. doi:10.1016/S1097-2765(00)00009-5
139. Moon Y-A, Liang G, Xie X, Frank-Kamenetsky M, Fitzgerald K, Koteliansky V,
et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver
and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab (2012)
15:240–6. doi:10.1016/j.cmet.2011.12.017
140. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al.
Increased intestinal permeability and tight junction alterations in nonalcoholic
fatty liver disease. Hepatology (2009) 49:1877–87. doi:10.1002/hep.22848
141. Thuy S, Ladurner R,VolynetsV,Wagner S, Strahl S, Königsrainer A, et al. Nonal-
coholic fatty liver disease in humans is associated with increased plasma endo-
toxin and plasminogen activator inhibitor 1 concentrations and with fructose
intake. J Nutr (2008) 138:1452–5.
142. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S,
et al. Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty
acid-induced inflammatory changes in the interaction between adipocytes and
macrophages. Arterioscler Thromb Vasc Biol. (2007) 27:84–91. doi:10.1161/01.
ATV.0000251608.09329.9a
143. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, et al. HMGB1 sig-
nals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 26:174–9.
doi:10.1097/01.shk.0000225404.51320.82
144. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and
non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect (2013)
19:338–48. doi:10.1111/1469-0691.12140
145. Soares J-B, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The
role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.
Hepatol Int (2010) 4:659–72. doi:10.1007/s12072-010-9219-x
146. Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, et al. Hyperre-
sponsivity to low-dose endotoxin during progression to nonalcoholic steato-
hepatitis is regulated by leptin-mediated signaling. Cell Metab (2012) 16:44–54.
doi:10.1016/j.cmet.2012.05.012
147. Miura K, Kodama Y, Inokuchi S, Schnabl B,Aoyama T, Ohnishi H, et al. Toll-like
receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.
Gastroenterology (2010) 139:323.e–34.e. doi:10.1053/j.gastro.2010.03.052
148. Pellicoro A,Ramachandran P, Iredale JP,Fallowfield JA. Liver fibrosis and repair:
immune regulation of wound healing in a solid organ. Nat Rev Immunol (2014)
14:181–94. doi:10.1038/nri3623
149. Brancato SK,Albina JE. Wound macrophages as key regulators of repair: origin,
phenotype, and function. Am J Pathol (2011) 178:19–25. doi:10.1016/j.ajpath.
2010.08.003
150. Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res
(2012) 347:245–56. doi:10.1007/s00441-011-1246-y
151. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC,
Smith AM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-
driven inflammation and fibrosis. PLoS Pathog (2009) 5:e1000371. doi:10.
1371/journal.ppat.1000371
152. Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al.
Differential Ly-6C expression identifies the recruited macrophage phenotype,
which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U
S A. (2012) 109:E3186–95. doi:10.1073/pnas.1119964109
153. Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al.
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mecha-
nism against alcoholic and nonalcoholic fatty liver disease. Hepatology (2014)
59:130–42. doi:10.1002/hep.26607
154. Wan J, Benkdane M, Alons E, Lotersztajn S, Pavoine C. M2 Kupffer cells pro-
mote hepatocyte senescence: an IL-6-dependent protective mechanism against
alcoholic liver disease. Am J Pathol (2014) 184:1763–72. doi:10.1016/j.ajpath.
2014.02.014
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 12 September 2014; accepted: 17 December 2014; published online: 22 January
2015.
Citation: Dey A, Allen J and Hankey-Giblin PA (2015) Ontogeny and polarization
of macrophages in inflammation: blood monocytes versus tissue macrophages. Front.
Immunol. 5:683. doi: 10.3389/fimmu.2014.00683
This article was submitted to Molecular Innate Immunity, a section of the journal
Frontiers in Immunology.
Copyright © 2015 Dey, Allen and Hankey-Giblin. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org January 2015 | Volume 5 | Article 683 | 15
